Literature DB >> 3022672

Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.

M A Pappolla.   

Abstract

Recently it has been shown by light microscopic immunochemistry that Lewy bodies (LBs) react with antibodies raised against neurofilament proteins (NFPs). Because of the ubiquity of the NFPs within neurons, the heterogeneous makeup of the inclusions, and the varying patterns of immunolabeling, we undertook to determine whether the labeled elements are indeed constituent filaments. Employing a preembedding technique, we investigated sections of the same LBs by light and electron immunochemistry. Decoration of the filaments was obtained with a monoclonal anti-NFP antibody. Whereas cores of mature LBs were unreactive by light microscopy, these same cores yielded a positive reaction at the ultrastructural level. Early LBs were intensely labeled in both the core and periphery. These results demonstrate that the filamentous profiles that form the LBs are antigenically identical to neurofilaments and suggest a posttranslational modification of the filaments as they "age" within the inclusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022672

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Authors:  B Lach; D Grimes; B Benoit; A Minkiewicz-Janda
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases.

Authors:  Ludovico Cantuti-Castelvetri; Hongling Zhu; Maria I Givogri; Robstein L Chidavaenzi; Aurora Lopez-Rosas; Ernesto R Bongarzone
Journal:  Neurobiol Dis       Date:  2012-02-04       Impact factor: 5.996

4.  Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions.

Authors:  M B Delisle; P Gorce; E Hirsch; J J Hauw; A Rascol; H Bouissou
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.

Authors:  D W Dickson; M L Schmidt; V M Lee; M L Zhao; S H Yen; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.

Authors:  J P Brion; A M Couck
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

9.  Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake.

Authors:  Hongxia Zhou; Cao Huang; Jianbin Tong; Weimin C Hong; Yong-Jian Liu; Xu-Gang Xia
Journal:  Int J Biol Sci       Date:  2011-06-09       Impact factor: 6.580

Review 10.  Role of Intermediate Filaments in Vesicular Traffic.

Authors:  Azzurra Margiotta; Cecilia Bucci
Journal:  Cells       Date:  2016-04-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.